137 related articles for article (PubMed ID: 9053804)
1. The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses bilaterally in rats with unilateral experimental mononeuropathy, an effect reversed by naloxone.
Yu LC; Hansson P; Lundeberg T
Neuroscience; 1996 Mar; 71(2):523-31. PubMed ID: 9053804
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal CGRP8-37-induced bilateral increase in hindpaw withdrawal latency in rats with unilateral inflammation.
Yu LC; Hansson P; Brodda-Jansen G; Theodorsson E; Lundeberg T
Br J Pharmacol; 1996 Jan; 117(1):43-50. PubMed ID: 8825341
[TBL] [Abstract][Full Text] [Related]
3. Opioid antagonists naloxone, beta-funaltrexamine and naltrindole, but not nor-binaltorphimine, reverse the increased hindpaw withdrawal latency in rats induced by intrathecal administration of the calcitonin gene-related peptide antagonist CGRP8-37.
Yu LC; Hansson P; Lundeberg T
Brain Res; 1995 Nov; 698(1-2):23-9. PubMed ID: 8581488
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal CGRP(8-37) results in a bilateral increase in hindpaw withdrawal latency in rats with a unilateral thermal injury.
Löfgren O; Yu LC; Theodorsson E; Hansson P; Lundeberg T
Neuropeptides; 1997 Dec; 31(6):601-7. PubMed ID: 9574827
[TBL] [Abstract][Full Text] [Related]
5. Unilateral injection of calcitonin gene-related peptide (CGRP) induces bilateral oedema formation and release of CGRP-like immunoreactivity in the rat hindpaw.
Bileviciute I; Stenfors C; Theodorsson E; Lundeberg T
Br J Pharmacol; 1998 Nov; 125(6):1304-12. PubMed ID: 9863661
[TBL] [Abstract][Full Text] [Related]
6. The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses in rats.
Yu LC; Hansson P; Lundeberg T
Brain Res; 1994 Aug; 653(1-2):223-30. PubMed ID: 7526959
[TBL] [Abstract][Full Text] [Related]
7. Opioids modulate the calcitonin gene-related peptide8-37-mediated hindpaw withdrawal latency increase in thermally injured rats.
Löfgren O; Yu LC; Theodorsson E; Hansson P; Lundeberg T
Neuropeptides; 1998 Apr; 32(2):173-7. PubMed ID: 9639257
[TBL] [Abstract][Full Text] [Related]
8. Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone.
Huang Y; Brodda-Jansen G; Lundeberg T; Yu LC
Brain Res; 2000 Aug; 873(1):54-9. PubMed ID: 10915810
[TBL] [Abstract][Full Text] [Related]
9. Effects of calcitonin gene-related peptide-(8-37) on withdrawal responses in rats with inflammation.
Yu LC; Hansson P; Lundeberg S; Lundeberg T
Eur J Pharmacol; 1998 Apr; 347(2-3):275-82. PubMed ID: 9653894
[TBL] [Abstract][Full Text] [Related]
10. Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems.
Ma W; Chabot JG; Powell KJ; Jhamandas K; Dickerson IM; Quirion R
Neuroscience; 2003; 120(3):677-94. PubMed ID: 12895509
[TBL] [Abstract][Full Text] [Related]
11. An interaction of opioids and galanin in dorsal horn of the spinal cord in mononeuropathic rats.
Zhang YP; Yu LC; Lundeberg T
Regul Pept; 2000 Jan; 86(1-3):89-94. PubMed ID: 10672907
[TBL] [Abstract][Full Text] [Related]
12. Effects of intrathecal galanin on nociceptive responses in rats with mononeuropathy.
Yu LC; Lundeberg S; An H; Wang FX; Lundeberg T
Life Sci; 1999; 64(13):1145-53. PubMed ID: 10210277
[TBL] [Abstract][Full Text] [Related]
13. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence.
Trang T; Ma W; Chabot JG; Quirion R; Jhamandas K
Pain; 2006 Dec; 126(1-3):256-71. PubMed ID: 16935424
[TBL] [Abstract][Full Text] [Related]
14. Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons.
Ma W; Zheng WH; Kar S; Quirion R
Neuroscience; 2000; 99(3):529-39. PubMed ID: 11029544
[TBL] [Abstract][Full Text] [Related]
15. Distinct calcitonin gene-related peptide expression pattern in primary afferents contribute to different neuropathic symptoms following chronic constriction or crush injuries to the rat sciatic nerve.
Zou Y; Xu F; Tang Z; Zhong T; Cao J; Guo Q; Huang C
Mol Pain; 2016; 12():1744806916681566. PubMed ID: 28256957
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway.
Xu W; Lundeberg T; Wang YT; Li Y; Yu LC
Neuroscience; 2003; 118(4):1015-22. PubMed ID: 12732246
[TBL] [Abstract][Full Text] [Related]
17. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.
Chen SR; Pan HL
Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888
[TBL] [Abstract][Full Text] [Related]
18. The role of spinal neuropeptides and prostaglandins in opioid physical dependence.
Trang T; Sutak M; Quirion R; Jhamandas K
Br J Pharmacol; 2002 May; 136(1):37-48. PubMed ID: 11976266
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive role of galanin in the spinal cord of rats with inflammation, an involvement of opioid systems.
Xiong W; Gao L; Sapra A; Yu LC
Regul Pept; 2005 Dec; 132(1-3):85-90. PubMed ID: 16214241
[TBL] [Abstract][Full Text] [Related]
20. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
